TSC2 and neoplasm: Introduction of constitutively-active Akt1 in HMT-3522 T4-2 breast cancer cells enhanced cell proliferation and survival and promoted tumor growth but inhibited invasion and motility by inducing phosphorylation (T1462) and degradation of TSC2 which regulates cell adhesion and migration via Rho-GTPase [92].